Schweitzer Fachinformationen
Wenn es um professionelles Wissen geht, ist Schweitzer Fachinformationen wegweisend. Kunden aus Recht und Beratung sowie Unternehmen, öffentliche Verwaltungen und Bibliotheken erhalten komplette Lösungen zum Beschaffen, Verwalten und Nutzen von digitalen und gedruckten Medien.
Monique Elseviers, Centre for Research and Innovation in Care, University of Antwerp, Belgium.
Björn Wettermark, Associate Professor in Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.
Morten Andersen, Visiting Professor, Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden; Senior Physician at the Department of Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden; Senior Researcher at the Research Unit for General Practice, University of Southern Denmark, Denmark.
Ria Benko, Associate Professor, Department of Clinical Pharmacy at the University of Szeged, Hungary.
Marion Bennie, Professor of Pharmacy Practice, University of Strathclyde, UK; Chief Pharmaceutical Adviser, NHS National Services Scotland, UK.
Brian Godman, Research Scientist, Karolinska Institutet, Stockholm, Sweden.
Janet Krska, Professor of Clinical and Professional Pharmacy, Medway School of Pharmacy, Universities of Greenwich and Kent, UK.
Elisabetta Poluzzi, Assistant Professor of Pharmacology, Department of Pharmacology, Faculty of Medicine, University of Bologna, Italy.
Katja Taxis, Associate Professor of Pharmacotherapy and Clinical Pharmacy, University of Groningen, Netherlands.
Vera Vlahovic-Palcevski, Professor, Department of Pharmacology, University of Rijeka Medical School, Croatia; Specialist in Clinical Pharmacology, University Hospital Rijeka, Croatia.
Robert Vander Stichele, practicing family physician in Ghent, Belgium.
List of contributors viii
Acknowledgements xiv
About the companion website xix
Part 1 Introduction
1 Introduction to drug utilization research 3 Björn Wettermark, Monique Elseviers, Anna Birna Almarsdóttir, Morten Andersen, Ria Benko, Marion Bennie, Irene Eriksson, Brian Godman, Janet Krska, Elisabetta Poluzzi, Katja Taxis, Robert Vander Stichele, Vera Vlahovic-Palcevski
Part 2 Methodology
2 Study designs in drug utilization research 15 Björn Wettermark, Mirko Di Martino, Monique Elseviers
3 Primary data collection for drug utilization research 29 Tatiana Chama Borges Luz, Evalill Nilsson
4 Secondary data sources for drug utilization research 39 Irene Eriksson, Luisa Ibáñez
5 Classifi cation systems for drugs and diseases 49 Marit Rønning, Stuart McTaggart
6 Measurement units of drug utilization 58 Hege Salvesen Blix
7 Individual-level drug utilization analyses 68 Jesper Hallas, Henrik Støvring, Anton Pottegård
8 Measurement of drug expenditure 77 Sabine Vogler, Jaana E. Martikainen
9 Basic statistical methods in drug utilization research 88 Douglas T. Steinke, Monique Elseviers
10 Visualization of drug utilization data 99 Maria Matuz, Ria Benko, Mikael Hoffmann
11 Multilevel analyses in drug utilization research 116 Juan Merlo
12 Defi ning and developing quality indicators for drug utilization 126 Stephen Campbell, Björn Wettermark, Morten Andersen
13 Qualitative methods in drug utilization research 139 Anna Birna Almarsdóttir, Pia Bastholm Rahmner
Part 3 Applied drug utilization research
Section A Comparative drug utilization research
14 Comparison of drug utilization across different geographical areas 153 Vera Vlahovic-Palcevski, Björn Wettermark, Luisa Ibáñez, Robert Vander Stichele
15 Comparison of drug utilization in different health care settings 160 Sean MacBride-Stewart, Ksenia Zagorodnikova, Irene Langner, Gisbert W. Selke
16 Time-dependent and seasonal variations in drug utilization 173 Eric Van Ganse, Laurent Laforest, Niels Adriaenssens
17 Comparative studies of patient and prescriber characteristics 184 Irene Eriksson, Ulf Bergman, Vera Vlahovic-Palcevski, Mia von Euler
18 Comparative studies of health systems 194 Tatiana Chama Borges Luz, Claudia Garcia Serpa Osorio-de-Castro, Björn Wettermark
Section B Drug utilization and health policy
19 Drug utilization and health policy 203 Brian Godman, Hye Young Kwon, Marion Bennie, Anna Birna Almarsdóttir
20 Managed introduction of new drugs 210 Brian Godman, Roberta Joppi, Marion Bennie, Saira Jan, Björn Wettermark
21 Management of drugs in the health care system 222 Brian Godman, Marion Bennie, Claudia Garcia Serpa Osorio-de-Castro, Vu Thi Thu Huong, Saira Jan
22 The pharmaceutical industry and health policy 231 Richard Torbett, Donald Han, Indranil Bagchi
Section C Drug utilization in specific populations
23 Drug utilization in pregnant women 240 Hedvig Nordeng
24 Drug utilization in the paediatric population 248 Antje Neubert, Katja Taxis, Ian C.K. Wong
25 Drug utilization in older people 259 Katja Taxis, David O'Sullivan, Shane Cullinan, Stephen Byrne
Section D Drug utilization in specific therapeutic areas
26 Drug utilization research in the area of antibiotics 270 Ria Benko, Marion Bennie, Samuel Coenen
27 Drug utilization research in the area of cardiovascular medicines 284 Elisabetta Poluzzi, Maarit Jaana Korhonen
28 Drug utilization research in the area of analgesics and psychotropics 294 Helga Zoëga, Alesha Smith, Nadia Barozzi
29 Drug utilization research in the area of biologicals 302 Carlo Piccinni, Luigi Naldi, Martin Neovius
30 Drug utilization research in the area of cancer drugs 315 Nils Wilking, Thomas Hofmarcher, Ulla Wilking, Bengt Jönsson
Section E Determinants of drug utilization
31 Health system perspectives 328 Paul Spivey, Brian Godman
32 Prescriber perspectives 336 Colin Bradley, Kathleen Holloway, Janet Krska
33 Patient perspectives 347 Janine Traulsen, Nicky Britten, Janet Krska
Section F Adherence and drug utilization research
34 An introduction to adherence research 355 Bernard Vrijens
35 Assessment of medication adherence in field research 361 Monique Elseviers, Bernard Vrijens
36 Assessment of adherence to drug treatment in database research 369 Jean-Pierre Grégoire, Jocelyne Moisan
37 Interventions to improve adherence to drug treatment 381 Marie-Paule Schneider, Jennifer Celio, Yoleen van Camp, Matthias Cavassini
Section G The role of drug utilization within the field of pharmacoepidemiology
38 Drug utilization research and risk management 392 Giampiero Mazzaglia, Peter Mol
39 Drug utilization research and pharmacovigilance 399 Emanuel Raschi, Fabrizio De Ponti
40 Drug utilization research and the regulator's perspective in pharmacovigilance 408 Xavier Kurz, Kevin Blake
41 Drug utilization research and outcomes research 417 Henrik Toft Sørensen, Gianluca Trifi rò
42 Drug utilization research and pharmacoeconomics 425 Cara Usher, Kathleen Bennett, Lorenzo G. Mantovani, Dyfrig Hughes
Section H Assessment and improvement of the quality of medicine use
43 Assessment of quality of prescribing using quality indicators 433 Petra Denig, Flora Haaijer-Ruskamp, Lisa Pont
44 Quality indicators for patient care in pharmacy practice 443 Hanne Herborg
45 Interventions that infl uence prescribing decisions and drug utilization 460 Jens Søndergaard, Dorte Gilså Hansen, Debra Rowett
46 Development, delivery and evaluation of implementation programmes 468 Elizabeth Roughead, Andrew Gilbert
47 Towards a better understanding of prescribingenhancement interventions 477 Frank May
Part 4 Epilogue
48 The many futures of drug utilization research 489 Hubert G.M. Leufkens, Frank May, Nicky Britten
Glossary 492
Index 497
Niels Adriaenssens Centre for General Practice Department of Primary and Interdisciplinary Care (ELIZA) and Laboratory of Medical Microbiology Vaccine & Infectious Disease Institute (VAXINFECTIO) University of Antwerp Belgium
Anna Birna Almarsdóttir Clinical Pharmacology Institute of Public Health University of Southern Denmark Denmark
Morten Andersen Centre for Pharmacoepidemiology Department of Medicine Karolinska Institutet Sweden and Research Unit of General Practice Department of Public Health University of Southern Denmark Denmark
Indranil Bagchi Pfizer United States
Nadia Barozzi Healthy4Life Basel Switzerland
Pia Bastholm Rahmner Medical Management Centre Department of Learning, Informatics, Management and Ethics Karolinska Institutet Sweden
Ria Benko Department of Clinical Pharmacy Faculty of Pharmacy University of Szeged Hungary
Kathleen Bennett National Centre for Pharmacoeconomics St James's Hospital Ireland
Marion Bennie Institute of Pharmacy and Biomedical Sciences University of Strathclyde Scotland and Information Services Scotland, NHS National Services Scotland, United Kingdom
Ulf Bergman Department of Clinical Pharmacology Karolinska Institutet Karolinska University Hospital Sweden
Kevin Blake Best Evidence Development Service Human Medicines Research and Development Support Division European Medicines Agency United Kingdom
Hege Salvesen Blix WHO Collaborating Centre for Drug Statistics Methodology Department of Pharmacoepidemiology Norwegian Institute of Public Health Norway
Colin Bradley Department of General Practice University College Cork Ireland
Nicky Britten University of Exeter Medical School United Kingdom
Stephen Byrne School of Pharmacy, University College Cork Ireland
Stephen Campbell Centre for Primary Care Institute of Population Health and Patient Safety Translational Research Centre Institute of Population Health University of Manchester United Kingdom
Matthias Cavassini Service of Infectious Disease Centre hospitalier universitaire vaudois and University of Lausanne Switzerland
Jennifer Celio Community Pharmacy School of Pharmaceutical Sciences Universities of Geneva, University of Lausanne Switzerland and Community Pharmacy Department of Ambulatory Care & Community Medicine University of Lausanne Switzerland
Samuel Coenen Department of Epidemiology and Social Medicine (ESOC) Department of Primary and Interdisciplinary Care (ELIZA) and Vaccine & Infectious Disease Institute (VAXINFECTIO) University of Antwerp Belgium
Shane Cullinan University College Cork Ireland
Petra Denig Clinical Pharmacy and Pharmacology University of Groningen, University Medical Center Groningen The Netherlands
Fabrizio De Ponti Pharmacology Unit Department of Medical and Surgical Sciences University of Bologna Italy
Mirko Di Martino Department of Epidemiology Lazio Regional Health Service, Roma Italy
Monique Elseviers Centre for Research and Innovation in Care Faculty of Medicine and Health Sciences University of Antwerp Belgium
Irene Eriksson Centre for Pharmacoepidemiology Department of Medicine Karolinska Institutet Sweden and Department of Healthcare Development Stockholm County Council Sweden
Andrew Gilbert School of Pharmacy and Medical Sciences University of South Australia Australia
Brian Godman Department of Laboratory Medicine Karolinska Institutet Sweden and Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom
Jean-Pierre Grégoire Faculty of Pharmacy Laval University Canada and Population Health and Optimal Health Practices Research Unit CHU de Québec Research Centre Canada
Flora Haaijer-Ruskamp Clinical Pharmacy and Pharmacology University of Groningen, University Medical Center Groningen The Netherlands
Jesper Hallas Clinical Pharmacology Institute of Public Health University of Southern Denmark Denmark
Donald Han Pfizer United States
Dorte Gilså Hansen Research Unit of General Practice Institute of Public Health University of Southern Denmark Denmark
Hanne Herborg Pharmakon Danish College of Pharmacy Practice Denmark
Mikael Hoffmann The NEPI Foundation Linköping University Sweden
Thomas Hofmarcher Department of Economics Lund University Sweden
Kathleen Holloway World Health Organization Regional Office for South-East Asia India
Dyfrig Hughes Centre for Health Economics & Medicines Evaluation Bangor University United Kingdom
Vu Thi Thu Huong Pharmacy Department, E Hospital, Hanoi, Vietnam and Administration Medical Services, Ministry of Health, Hanoi Vietnam
Luisa Ibáñez Foundation of the Catalan Institute of Pharmacology (FICF) Spain
Saira Jan Department of Clinical Pharmacy Management Horizon Blue Cross Blue Shield of New Jersey United States and Clinical Professor Rutgers State University of New Jersey, Piscataway New Jersey United States
Bengt Jönsson Stockholm School of Economics Sweden
Roberta Joppi Pharmaceutical Drug Department Azienda Sanitaria Locale of Verona Italy
Maarit Jaana Korhonen Department of Pharmacology Drug Development and Therapeutics University of Turku Finland
Janet Krska Medway School of Pharmacy Universities of Greenwich and Kent United Kingdom
Xavier Kurz Pharmacovigilance Division European Medicines Agency United Kingdom
Hye Young Kwon Institute of Health and Environment Seoul National University South Korea
Laurent Laforest PharmacoEpidemiology Lyon (PEL), HESPER Unit, Claude-Bernard University-Lyon1 France
Irene Langner AOK Research Institute (WIdO) Germany
Hubert G.M. Leufkens Division of Pharmacoepidemiology and Clinical Pharmacology Utrecht Institute for Pharmaceutical Sciences Utrecht University The Netherlands
Tatiana Chama Borges Luz René Rachou Research Center Oswaldo Cruz Foundation Brazil
Sean MacBride-Stewart Prescribing and Pharmacy Support Unit NHS Greater Glasgow and Clyde United Kingdom
Lorenzo G. Mantovani Department of Statistics School of Medicine University of Milano Italy
Jaana E. Martikainen Research Department Social Insurance Institution (Kela) Finland
Maria Matuz Department of Clinical Pharmacy Faculty of Pharmacy University of Szeged Hungary
Frank May Drug and Therapeutics Information Service, Repatriation General Hospital, Daw Park, South Australia School of Pharmacy, Faculty of Health and Behavioural Sciences, University of Queensland, Australia
Giampiero Mazzaglia Scientific and Regulatory Management Department Human Medicines Evaluation Division European Medicines Agency United Kingdom
Stuart McTaggart National Health Service for Scotland United Kingdom
Juan Merlo Unit for Social Epidemiology Faculty of Medicine Lund University Skåne University Hospital Sweden
Jocelyne Moisan Faculty of Pharmacy Laval University Canada and Population Health and Optimal Health Practices Research Unit CHU de Québec Research Centre Canada
Peter Mol Medicines Evaluation Board The Netherlands and Department of Clinical Pharmacy and Pharmacology University Medical Centre Groningen University of Groningen The Netherlands
Luigi Naldi Unità Complessa di Dermatologia Azienda Ospedaliera Papa Giovanni XXIII and Centro Studi GISED (Italian Group for Epidemiologic Research in Dermatology) Italy
Martin Neovius Clinical Epidemiology Unit Department of Medicine Karolinska Institutet Sweden
Antje Neubert Department of Paediatric and Adolescent Medicine University Hospital Erlangen Germany
Evalill Nilsson The Research and Development Department of Local Health Care Östergötland Region Sweden
Hedvig Nordeng Pharmaco-Epidemiology and Drug Safety Research Group School of Pharmacy University of...
Dateiformat: ePUBKopierschutz: Adobe-DRM (Digital Rights Management)
Systemvoraussetzungen:
Das Dateiformat ePUB ist sehr gut für Romane und Sachbücher geeignet – also für „fließenden” Text ohne komplexes Layout. Bei E-Readern oder Smartphones passt sich der Zeilen- und Seitenumbruch automatisch den kleinen Displays an. Mit Adobe-DRM wird hier ein „harter” Kopierschutz verwendet. Wenn die notwendigen Voraussetzungen nicht vorliegen, können Sie das E-Book leider nicht öffnen. Daher müssen Sie bereits vor dem Download Ihre Lese-Hardware vorbereiten.Bitte beachten Sie: Wir empfehlen Ihnen unbedingt nach Installation der Lese-Software diese mit Ihrer persönlichen Adobe-ID zu autorisieren!
Weitere Informationen finden Sie in unserer E-Book Hilfe.
